Cargando…

Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) has become one of the most lethal cancers, for which the recurrence and survival rates remain unfavorable. The tumor necrosis factor (TNF) family is involved in tumorigenesis and tumor progression. Various long non-coding RNAs (lncRNAs) play important roles by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jin-Hua, Wu, Xuan, Wang, Zi-Ming, Liu, Zi-Yang, He, Bao-Xia, Song, Wen-Ping, Zhang, Wen-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089852/ https://www.ncbi.nlm.nih.gov/pubmed/37065578 http://dx.doi.org/10.21037/jtd-23-184

Ejemplares similares

The role of LncRNAs in tumor immunotherapy
por: Pan, Xuan, et al.
Publicado: (2023)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
por: Sun, Yimin, et al.
Publicado: (2022)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma
por: Zhou, Qianhui, et al.
Publicado: (2023)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
por: Sun, Jie, et al.
Publicado: (2020)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis
por: Li, Jianliang, et al.
Publicado: (2019)

A Robust Signature Based on Autophagy-Associated LncRNAs for Predicting Prognosis in Lung Adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2020)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2016)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma
por: Qiu, Mantang, et al.
Publicado: (2016)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
por: Guo, Ying, et al.
Publicado: (2023)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma
por: Liu, Anbang, et al.
Publicado: (2023)

Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
por: Yang, Zhuo, et al.
Publicado: (2023)

Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma
por: Jin, Donghui, et al.
Publicado: (2020)

LncRNAs and regulated cell death in tumor cells
por: Wu, Yingying, et al.
Publicado: (2023)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017)

The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer
por: Chen, Yu, et al.
Publicado: (2021)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma
por: He, Chenxi, et al.
Publicado: (2022)

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)

Functions and properties of nuclear lncRNAs—from systematically mapping the interactomes of lncRNAs
por: Guh, Chia-Yu, et al.
Publicado: (2020)

Implication of lncRNAs in pathogenesis of esophageal cancer
por: Tang, Wei-Wei, et al.
Publicado: (2015)

Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma
por: Jung, Jiyoon, et al.
Publicado: (2021)

Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma
por: He, Chunming, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
por: Liang, Deku, et al.
Publicado: (2021)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ao06vkqj65kjfm7a0hffasu2gd